BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zhang HQ, Li J, Tan CL, Chen YH, Zheng ZJ, Liu XB. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. World J Gastrointest Oncol 2022; 14(10): 1903-1917 [PMID: 36310705 DOI: 10.4251/wjgo.v14.i10.1903]
URL: https://www.wjgnet.com/1007-9327/full/v14/i10/1903.htm
Number Citing Articles
1
Sung Woo Ko, Seung Bae Yoon. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancerWorld Journal of Gastrointestinal Oncology 2023; 15(4): 632-643 doi: 10.4251/wjgo.v15.i4.632
2
Qingquan Tan, Chen Chen, Ziyao Wang, Haoqi Zhang, Xubao Liu, Nengwen Ke. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large populationEuropean Journal of Radiology 2023; 165: 110952 doi: 10.1016/j.ejrad.2023.110952
3
Lauren M. Janczewski, Joanna Buchheit, Ryan C. Jacobs, Dominic Vitello, Amy Wells, John Abad, David J. Bentrem, Akhil Chawla. Utilization and survival outcomes of neoadjuvant chemotherapy for early‐stage gastric cancerJournal of Surgical Oncology 2024; 130(2): 249 doi: 10.1002/jso.27732
4
Chun-Ye Zhang, Shuai Liu, Ming Yang. Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment optionsWorld Journal of Gastroenterology 2022; 28(48): 6827-6845 doi: 10.3748/wjg.v28.i48.6827
5
Seung Bae Yoon, Sung Woo Ko. Clinical Utility of Portal Venous Circulating Tumor Cells in Pancreatic CancerJournal of Digestive Cancer Research 2023; 11(1): 21 doi: 10.52927/jdcr.2023.11.1.21